Clinical monoclonal B lymphocytosis versus rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features

Clinical Cancer Research

Volumn 19, Issue 21, 2013, Pages 5890-5900

  Morabito, Fortunato ^a   Mosca, Laura ^b   Cutrona, Giovanna ^c   Agnelli, Luca ^b   Tuana, Giacomo ^b   Ferracin, Manuela ^e   Zagatti, Barbara ^e   Lionetti, Marta ^b   Fabris, Sonia ^b   Maura, Francesco ^b   Matis, Serena ^d   Gentile, Massimo ^a   Vigna, Ernesto ^a   Colombo, Monica ^d   Massucco, Carlotta ^d   Recchia, Anna Grazia ^a   Bossio, Sabrina ^a   De Stefano, Laura ^a   Ilariucci, Fiorella ^f   Musolino, Caterina ^g   Molica, Stefano ^h   Di Raimondo, Francesco ^j   Cortelezzi, Agostino ^b   Tassone, Pierfrancesco ⁱ   Negrini, Massimo ^e   Monti, Sara ^k   Rossi, Davide ^k   Gaidano, Gianluca ^k   Ferrarini, Manlio ^d   Neri, Antonino ^b   more..

^a AO of Cosenza ^*  (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SS Molecular Diagnostics   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e UNIVERSITY OF FERRARA   (Italy)

^f S MARIA NUOVA HOSPITAL   (Italy)

^g UNIVERSITY OF MESSINA   (Italy)

^h Haemophilia Center   (Italy)

ⁱ UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^j UNIVERSITY OF CATANIA   (Italy)

^k UNIVERSITY OF EASTERN PIEDMONT   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; MICRORNA; NOTCH1 RECEPTOR; PROTEIN KINASE ZAP 70;

ADULT; AGED; ARTICLE; CANCER STAGING; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN HEAVY CHAIN GENE; MAJOR CLINICAL STUDY; MALE; MONOCLONAL B CELL LYMPHOCYTOSIS; NOTCH1 GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; SF3B1 GENE;

ADULT; AGED; ANTIGENS, CD38; B-LYMPHOCYTES; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTOSIS; MALE; MICRORNAS; MIDDLE AGED; MUTATION; NEOPLASM STAGING; PHOSPHOPROTEINS; PROGNOSIS; RECEPTOR, NOTCH1; RIBONUCLEOPROTEIN, U2 SMALL NUCLEAR; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 84887064418     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-0622     Document Type: Article

References (42)

1. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia.NEngl J Med 2005;352: 804-15.
2. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute- Working Group 1996 guidelines. Blood 2008;111: 5446-56.
3. Ghia P, Prato G, Scielzo C, Stella S, Geuna M, Guida G, et al. Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood 2004;103: 2337-42.
4. Nieto WG, Almeida J, Romero A, Teodosio C, Lopez A, Henriques AF, et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. Blood 2009;114: 33-7.
5. Rawstron AC, Bennett FL, O'Connor SJ, Kwok M, Fenton JA, Plummer M, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008;359: 575-83.
6. Rawstron AC. Monoclonal B-cell lymphocytosis. Hematology Am Soc Hematol Educ Program 2009;430-9.
7. Shanafelt TD, Ghia P, Lanasa MC, Landgren O, Rawstron AC. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia 2010;24: 512-20.
8. Marti GE, Rawstron AC, Ghia P, Hillmen P, Houlston RS, Kay N, et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005;130: 325-32.
9. Mulligan CS, Thomas ME, Mulligan SP. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008;359: 2065-6.
10. Fung SS, Hillier KL, Leger CS, Sandhu I, Vickars LM, Galbraith PF, et al. Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis. Leuk Lymphoma 2007;48: 1087-91.
11. Shanafelt TD, Kay NE, Jenkins G, Call TG, Zent CS, Jelinek DF, et al. Bcell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Blood 2009;113: 4188-96.
12. Shanafelt TD, Kay NE, Rabe KG, Call TG, Zent CS, Maddocks K, et al. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. J Clin Oncol 2009;27: 3959-63.
13. Fazi C, Scarfo L, Pecciarini L, Cottini F, Dagklis A, Janus A, et al. General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. Blood 2011;118: 6618-25.
14. Rawstron AC, Shanafelt T, Lanasa MC, Landgren O, Hanson C, Orfao A, et al. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytometry B Clin Cytom 2010;78 Suppl 1:S19-S23.
15. Ghia P, Caligaris-Cappio F. Monoclonal B-cell lymphocytosis: right track or red herring? Blood 2012;119: 4358-62.
16. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87: 4990-7.
17. Rossi D, Rasi S, Fabbri G, Spina V, Fangazio M, Forconi F, et al. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood 2012;119: 521-9.
18. Rossi D, Rasi S, Spina V, Bruscaggin A, Monti S, Ciardullo C, et al. Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia. Blood 2013;121: 1403-12.
19. Cutrona G, Colombo M, Matis S, Fabbi M, Spriano M, Callea V, et al. Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells. Haematologica 2008;93: 413-22.
20. Domingo-Domenech E, Domingo-Claros A, Gonzalez-Barca E, Beneitez D, Alonso E, Romagosa V, et al. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients. Haematologica 2002;87: 1021-7.
21. Ibrahim S, Keating M, Do KA, O'Brien S, Huh YO, Jilani I, et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 2001;98: 181-6.
22. Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, et al. ZAP-70 expression as a surrogate for immunoglobulin-variableregion mutations in chronic lymphocytic leukemia. N Engl J Med 2003;348: 1764-75.
23. Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG, et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004;351: 893-901.
24. Morabito F, Cutrona G, Gentile M, Matis S, Todoerti K, Colombo M, et al. Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia. Br J Haematol 2009;146: 44-53.
25. Le Garff-Tavernier M, Ticchioni M, Brissard M, Salmon C, Raynaud S, Davi F, et al. National standardization of ZAP-70 determination by flow cytometry: the French experience. Cytometry B Clin Cytom 2007;72: 103-8.
26. Letestu R,Rawstron A, Ghia P, Villamor N, Boeckx N, Boettcher S, et al. Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: a multicentric international harmonization process. Cytometry B Clin Cytom 2006;70: 309-14.
27. Wang YH, Fan L, Xu W, Li JY. Detection methods of ZAP-70 in chronic lymphocytic leukemia. Clin Exp Med 2012;12: 69-77.
28. Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998;102: 1515-25.
29. Maura F, Cutrona G, Fabris S, Colombo M, Tuana G, Agnelli L, et al. Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia. PLoS ONE 2011;6:e24313.
30. Visco C, Maura F, Tuana G, Agnelli L, Lionetti M, Fabris S, et al. Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors. Clin Cancer Res 2012;18: 1870-8.
31. Fabris S, Mosca L, Todoerti K, Cutrona G, Lionetti M, Intini D, et al. Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 2008; 47: 781-93.
32. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98: 5116-21.
33. Agnelli L, Fabris S, Bicciato S, Basso D, Baldini L, Morabito F, et al. Upregulation of translational machinery and distinct genetic subgroups characterise hyperdiploidy in multiple myeloma. Br J Haematol 2007;136: 565-73.
34. Goeman JJ, van de Geer SA, van Houwelingen HC. Testing against a high dimensional alternative. J Roy Stat Soc B 2006;68: 477-93.
35. Shanafelt TD, Witzig TE, Fink SR, Jenkins RB, Paternoster SF, Smoley SA, et al. Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. J Clin Oncol 2006;24: 4634-41.
36. Stilgenbauer S, Sander S, Bullinger L, Benner A, Leupolt E, Winkler D, et al. Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival. Haematologica 2007; 92: 1242-5.
37. Young RM, Staudt LM. Targeting pathological B-cell receptor signalling in lymphoid malignancies. Nat Rev Drug Discov 2013;12: 229-43.
38. Lanasa MC, Allgood SD, Slager SL, Dave SS, Love C, Marti GE, et al. Immunophenotypic and gene expression analysis of monoclonal Bcell lymphocytosis shows biologic characteristics associated with good prognosis CLL. Leukemia 2011;25: 1459-66.
39. Visone R, Veronese A, Balatti V, Croce CM. MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia. Oncotarget 2012;3: 195-202.
40. Kovaleva V, Mora R, Park YJ, Plass C, Chiramel AI, Bartenschlager R, et al. miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. Cancer Res 2012;72: 1763-72.
41. Schillaci R, Galeano A, Becu-Villalobos D, Spinelli O, Sapia S, Bezares RF. Autocrine/paracrine involvement of insulin-like growth factor-I and its receptor in chronic lymphocytic leukaemia. Br J Haematol 2005; 130: 58-66.
42. Molica S, Vitelli G, Mirabelli R, Digiesi G, Giannarelli D, Cuneo A, et al. Serum insulin-like growth factor is not elevated in patients with early Bcell chronic lymphocytic leukemia but is still a prognostic factor for disease progression. Eur J Haematol 2006;76: 51-7.